Ambu (AMBU B) Stock Overview
Researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AMBU B from our risk checks.
AMBU B Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 83.15 |
| 52 Week High | DKK 143.90 |
| 52 Week Low | DKK 80.10 |
| Beta | 1.54 |
| 1 Month Change | -21.92% |
| 3 Month Change | -8.63% |
| 1 Year Change | -32.86% |
| 3 Year Change | -16.06% |
| 5 Year Change | -59.79% |
| Change since IPO | 4,755.48% |
Recent News & Updates
Recent updates
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward
Oct 07
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 27Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?
Aug 11Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
Jul 12Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye
May 15Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?
Mar 14Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Feb 02Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Jan 27Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Jan 12Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Dec 31
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Nov 28Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Nov 13Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Nov 07Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
Sep 02Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Aug 06Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
Apr 06Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
Mar 14Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 01A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
Jan 02Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Oct 31Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 22Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Aug 19Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?
Jul 12Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Jun 22Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet
May 07Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Mar 24We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Jan 20Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Dec 08Shareholder Returns
| AMBU B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -17.4% | 0.8% | -1.5% |
| 1Y | -32.9% | -27.1% | -35.2% |
Return vs Industry: AMBU B underperformed the Danish Medical Equipment industry which returned -27.1% over the past year.
Return vs Market: AMBU B exceeded the Danish Market which returned -35.2% over the past year.
Price Volatility
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in DK Market | 9.9% |
| 10% least volatile stocks in DK Market | 2.4% |
Stable Share Price: AMBU B has not had significant price volatility in the past 3 months compared to the Danish market.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,384 | Britt Jensen | www.ambu.com |
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators.
Ambu A/S Fundamentals Summary
| AMBU B fundamental statistics | |
|---|---|
| Market cap | DKK 22.16b |
| Earnings (TTM) | DKK 609.00m |
| Revenue (TTM) | DKK 6.04b |
Is AMBU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU B income statement (TTM) | |
|---|---|
| Revenue | DKK 6.04b |
| Cost of Revenue | DKK 2.40b |
| Gross Profit | DKK 3.63b |
| Other Expenses | DKK 3.02b |
| Earnings | DKK 609.00m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 04, 2026
| Earnings per share (EPS) | 2.28 |
| Gross Margin | 60.18% |
| Net Profit Margin | 10.09% |
| Debt/Equity Ratio | 0.08% |
How did AMBU B perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 05:32 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ambu A/S is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Alexander Berglund | BofA Global Research |